Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKesson
Covington
Farmers Insurance
UBS
Medtronic
AstraZeneca
Deloitte
Baxter

Generated: December 10, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074732

« Back to Dashboard

NDA 074732 describes TAMOXIFEN CITRATE, which is a drug marketed by Actavis Labs Fl Inc, Aegis Pharms, Apotex, Ivax Sub Teva Pharms, Mayne Pharma, Mylan, Pharmachemie, Roxane, Teva, and Zydus Pharms Usa Inc, and is included in eleven NDAs. It is available from eleven suppliers. Additional details are available on the TAMOXIFEN CITRATE profile page.

The generic ingredient in TAMOXIFEN CITRATE is tamoxifen citrate. There are sixteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the tamoxifen citrate profile page.
Summary for 074732
Tradename:TAMOXIFEN CITRATE
Applicant:Mylan
Ingredient:tamoxifen citrate
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 074732
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 074732 ANDA Mylan Pharmaceuticals Inc. 0378-0144 0378-0144-91 60 TABLET in 1 BOTTLE (0378-0144-91)
TAMOXIFEN CITRATE tamoxifen citrate TABLET;ORAL 074732 ANDA Mylan Pharmaceuticals Inc. 0378-0274 0378-0274-93 30 TABLET in 1 BOTTLE (0378-0274-93)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 20MG BASE
Approval Date:Feb 20, 2003TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 10MG BASE
Approval Date:Feb 20, 2003TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Federal Trade Commission
Daiichi Sankyo
Accenture
Julphar
UBS
Citi
Farmers Insurance
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.